University of Florida researchers determined an FDA-approved program deters pregnant women from starting a potentially harmful immunosuppressive drug. But for women taking the drug, the program was not effective at reducing conception.
The State University System of Florida Board of Governors has selected the University of Florida to lead a statewide consortium studying health outcomes related to medical marijuana. UF will lead the Consortium for Medical Marijuana Clinical Outcomes Research, which will be composed of public and private universities engaged in research…
The Centers for Medicare and Medicaid Services criteria are used to flag high-risk patients for opioid abuse and overdose.
A new study by University of Florida researchers questions the accuracy of the criteria used by the Centers for Medicare and Medicaid Services to identify patients at risk of opioid abuse and overdose.
The center will unite researchers interested in using big data to evaluate drugs and the safety of medications in real-world populations.
The study, published in the journal Hepatology, examined the clinical and economic outcomes of direct-acting antiviral therapy, which cures hepatitis C in nearly 95 percent of patients.
A pair of Orlando pharmacy students also placed in the top 10 of the Clinical Skills Challenge at ASHP Midyear.
As president-elect, Winterstein will serve on the executive board and chair the strategic planning committee. She joined ISPE in 2000 and has held numerous leadership roles during the past two decades.
As a loan repayment awardee, Brown will receive financial support paying off his student debt, in return for a commitment to engage in NIH mission-relevant research.
The nearly $3 million grant will enhance the FDA’s capability to conduct drug safety studies on maternal and infant outcomes involving exposure to medications during pregnancy.